NxStage Medical Inc. | Key People and Executives
Jeffrey H. Burbank
Chief Executive Officer & Director
Robert G. Funari
Chairman
Jean K. Mixer
Independent Director
James J. Peters
Independent Director
Heyward R. Donigan
Independent Director
Reid S. Perper
Independent Director
Craig W. Moore
Independent Director
Daniel A. Giannini
Independent Director
Earl Ray Lewis
Independent Director
Jeffrey H. Burbank
Chief Executive Officer & Director
Thomas F. Shea
Chief Operating Officer & Senior Vice President
Matthew W. Towse
Chief Financial Officer, Treasurer & Senior VP
Allan J. Collins
Chief Medical Officer
Todd M. Snell
Senior VP-Regulatory & Clinical Affairs
Lisa Curtis
Senior Vice President-International
Mark T. Wyeth
Senior VP-Product Development & Innovation
Jeffrey Rains
Senior Vice President-Sales & Marketing
Kristen K. Sheppard
Vice President-Investor & Media Relations
Darren R. Scandone
Senior Vice President-Human Resources
Winifred L. Swan
Secretary, Senior Vice President & General Counsel
Robert G. Funari
Chairman
Jean K. Mixer
Independent Director
James J. Peters
Independent Director
Heyward R. Donigan
Independent Director
Reid S. Perper
Independent Director
Craig W. Moore
Independent Director
Daniel A. Giannini
Independent Director
Earl Ray Lewis
Independent Director
| Address |
350 Merrimack Street
Lawrence Massachusetts 01843
United States
|
|
Employees
|
- |
| Website |
http://www.nxstage.com |
| Updated |
09/14/2018 |
| NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. |
